Catalyst
Slingshot members are tracking this event:
Lipocine (LPCN) receives FDA CRL for the 2nd time regarding its refiled MA for testosterone replacement therapy candidate Tlando
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| LPCN |
|
|
||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 11, 2019
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Testosterone Replacement Therapy, Tlando
